Reply to the letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial’
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Cardiovascular System & Hematology (Science Metrix)
- Heart (MeSH)
- Heart Failure (MeSH)
- Humans (MeSH)